0RU5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Oncoinvent ASA

Watchlist Manager

Watchlist

Price: 0.476 NOK -4.8% Market Closed

Market Cap: kr198.3m

O	Oncoinvent ASA LSE:0RU5	NO
F	Fresenius Medical Care AG & Co KGaA LSE:0H9X	DE
	Heron Neutron Medical Corp TWSE:7799	TW
T	Taisei Corp XMUN:TKK1	JP
	Velesto Energy Bhd OTC:VLSOF	MY

Profitability Summary

Oncoinvent ASA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 133%

Negative 3Y Average Operating Margin

-36 390%

Operating Margin is Increasing

-66 585% > -2 133%

Negative Net Margin

-1 990%

Negative 3Y Average Net Margin

-35 660%

Net Margin is Increasing

-66 278% > -1 990%

Negative Free Cash Flow Margin

-2 550%

Negative 3Y Average Free Cash Flow Margin

-40 767%

Free Cash Flow Margin is Increasing

-72 509% > -2 550%

Negative ROE

-89%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1 050%

Declining ROIC

1 378% > -1 089%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.